semaglutide with hypothyroidism Patients Who Lose Weight After Starting GLP-1s More Likely to See Thyroid Level Improvement Semaglutide with Underactive Thyroid: Safety

Zepbound Savings, Coverage & LillyDirect (2026) Reuters

With demand showing no signs of slowing, more patients are likely to display these unusual patterns on their PET-CT scans

The insurance landscape for obesity drugs is evolving

Patients presenting with unexplained IGF-1 elevation, dysplastic skin lesions, injection site infections, hormonal irregularities, or unusual cardiovascular symptoms should be asked directly about peptide use

Retatrutide is a synthetic peptide that activates three distinct hormone receptors: GLP-1R, GIPR, and glucagon receptor (GCGR)

Weeks 512: Reduced portions feel natural, steady weight loss begins